Vaishampayan, U. N., Fontana, J., Heilbrun, L. K., Smith, D., Heath, E., Dickow, B., & Figg, W. D. (2013). Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer.
Παραπομπή Chicago StyleVaishampayan, Ulka N., Joseph Fontana, Lance K. Heilbrun, Daryn Smith, Elisabeth Heath, Brenda Dickow, και William D. Figg. Phase II Trial of Bevacizumab and Satraplatin in Docetaxel-pretreated Metastatic Castrate-resistant Prostate Cancer. 2013.
Παραπομπή MLAVaishampayan, Ulka N., et al. Phase II Trial of Bevacizumab and Satraplatin in Docetaxel-pretreated Metastatic Castrate-resistant Prostate Cancer. 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.